Lantheus Holdings, Inc. Effective Tax Rate
Lantheus Holdings, Inc. (LNTH) reported Effective Tax Rate of 20.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- Lantheus Holdings, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 20.00%, a 18.70% decline year-over-year.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 24.30%, a 0.41% decline year-over-year.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 34.50%, a 34.77% increase year-over-year.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 24.60%, a 6.82% decline year-over-year.
- Lantheus Holdings, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 25.60%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 20.00% 10-Q · filed 2026-08-06 | 22.70% 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 24.30% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 25.60% 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 34.50% 10-Q · filed 2025-11-06 | 26.30% 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 24.60% 10-Q · filed 2026-08-06 | 24.50% 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 24.40% 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | 25.60% 10-Q · filed 2025-11-06 | 24.90% 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 26.40% 10-Q · filed 2025-08-06 | 24.40% 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | 23.50% 10-Q · filed 2025-05-07 | |||
| 2023-09-30 | 17.50% 10-Q · filed 2024-11-06 | 18.10% 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 23.90% 10-Q · filed 2024-07-31 | 18.90% 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | 74.70% 10-Q · filed 2024-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |